Back to Report Store Home

Emerging Pharmaceutical Market in South Africa - Proposed Introduction of New Drug Regulatory Agency (SAHPRA) to Accelerate Drug Registration Process

  • Published: Jun-2012
  • Report Code: GBIHC204MR
  • Report Format: pdf

Description

Table of Contents

1 Table of Contents

1.1 List of Tables

1.2 List of Figures

2 Emerging Pharmaceutical Market: South Africa – Executive Summary

2.1 The South African Pharmaceutical Market is Forecast to Show High Growth until 2018

2.2 Proposed Introduction of New Drug Regulatory Agency to Accelerate Drug Registration Process

2.3 South Africa’s Disease Burden for HIV/AIDS and Tuberculosis is the Highest Globally

2.4 Emerging Service Industries such as the – Contract Research Organization Industry to Boost Overall Performance

3 Emerging Pharmaceutical Market: South Africa – Introduction

3.1 Introduction

3.2 GBI Research Report Guidance

4 Emerging Pharmaceutical Market: South Africa – Industry Characteristics

4.1 Pharmaceutical Market Size and Growth in South Africa

4.2 Environmental Disease Burden

4.2.1 HIV/AIDS

4.2.2 Tuberculosis

4.3 Patented and Generic Drugs Market Share

4.4 Imports and Exports

4.4.1 Imports

4.4.2 Exports

4.4.3 Balance of Trade

4.5 Key Domestic Players in South Africa

4.5.1 Aspen Pharmacare

4.5.1.1 Overview

4.5.1.2 SWOT Analysis

4.5.2 Adcock Ingram

4.5.2.1 Overview

4.5.2.2 SWOT Analysis

4.5.3 Cipla Medpro

4.5.3.1 Overview

4.5.3.2 SWOT Analysis

4.6 Key Foreign Players in South Africa

4.6.1 Sanofi

4.6.1.1 Overview

4.6.1.2 SWOT Analysis

4.6.2 Pfizer

4.6.2.1 Overview

4.6.2.2 SWOT Analysis

4.6.3 Roche

4.6.3.1 Overview

4.6.3.2 SWOT Analysis

4.6.4 Ranbaxy

4.6.4.1 Overview

4.6.4.2 SWOT Analysis

4.6.5 GlaxoSmithKline

4.6.5.1 Overview

4.6.5.2 SWOT Analysis

4.6.6 Merck & Co

4.6.6.1 Overview

4.6.6.2 SWOT Analysis

4.6.7 Novartis

4.6.7.1 Overview

4.6.7.2 SWOT Analysis

4.7 Market Drivers and Restraints

4.7.1 Drivers

4.7.1.1 Well-established and High-quality Infrastructure

4.7.1.2 Growth in Contract Research Organization Industry Fuelled by a Number of Factors

4.7.1.3 Establishing the Generics Industry

4.7.1.4 Better Regulatory Framework due to Introduction of South African Health Products Regulatory Authority

4.7.2 Restraints

4.7.2.1 Slow Drug Approval Process Increases the Time it Takes Drugs Reach Patients

4.7.2.2 Counterfeit Market to Limit the Investments of Foreign Players in the Domestic Market

4.7.2.3 Government Healthcare Reform Plans Aimed at Cutting Drug Expenditure

4.7.2.4 Inadequate Funds Available for Public Healthcare System

4.8 PESTLE Analysis

5 Emerging Pharmaceutical Market: South Africa – Macroeconomic Environment

5.1 Demographic Analysis

5.1.1 Introduction

5.1.2 Population Size, Growth and Structure

5.1.3 Changes in Life Expectancy at Birth

5.1.4 Infant Mortality Rate

5.1.5 Rural/Urban Distribution

5.1.6 Population by Gender

5.2 Gross Domestic Product

5.3 Healthcare Expenditure

5.4 Healthcare System

5.4.1 Health Workforce and Infrastructure in South Africa

5.4.1.1 Physicians

5.4.1.2 Nursing and Midwifery Personnel

5.4.1.3 Dentistry Personnel

5.4.1.4 Pharmaceutical Personnel

5.4.1.5 Hospital Infrastructure

6 Emerging Pharmaceutical Market: South Africa – Healthcare Regulation

6.1 Pharmaceutical Regulation in South Africa

6.2 Intellectual Property Rights

6.3 Health Insurance Coverage

6.4 Pricing and Reimbursement

6.4.1 Pricing

6.4.2 Reimbursement

6.5 Clinical Trials

7 Emerging Pharmaceutical Market: South Africa – Industry Trends

7.1 Strategic Consolidations

7.2 Mergers and Acquisitions

7.2.1 Deals by Year

7.2.2 Deals by Type

7.2.3 Deals by Value

7.2.4 Top M&A Deals

7.2.4.1 Nycomed Acquires Nycomed Madaus

7.2.4.2 Adcock Ingram Acquires Donmed Pharmaceuticals

7.2.4.3 Cadila Healthcare Acquires Simayla Pharmaceuticals

7.2.4.4 Enaleni Pharmaceuticals Acquires Bioharmony

7.2.4.5 Paladin Labs Acquires 35% Stake in Pharmaplan

7.3 Licensing Agreements

7.3.1 Top Licensing Deals

7.3.1.1 Recordati Enters into a Licensing Agreement with Pharmaplan

8 Emerging Pharmaceutical Market: South Africa – Contract Research Organization Industry

8.1 Contract Research Organizations

8.2 Key International Contract Research Organization Players in South Africa

8.2.1 Quintiles

8.2.1.1 Business Description

8.2.2 Pharmaceutical Product Development

8.2.2.1 Business Description

8.2.3 Inc Research

8.2.3.1 Business Description

8.2.4 Parexel

8.2.4.1 Business Description

8.2.5 Icon plc.

8.2.5.1 Business Description

8.2.6 PRA International

8.2.6.1 Business Description

8.3 Key Domestic Contract Research Organization Players in South Africa

8.3.1 African Clinical Research Organization

8.3.1.1 Business Description

8.3.2 OnQ

8.3.2.1 Business Description

9 Emerging Pharmaceutical Market: South Africa – Appendix

9.1 Market Definitions

9.2 Abbreviations

9.3 Research Methodology

9.3.1 Industry Performance

9.3.2 Macroeconomic Environment

9.3.3 Healthcare Regulations

9.3.4 Industry Trends

9.4 Contact Us

9.5 Disclaimer

9.6 Sources

License Details
Electronic PDF copy delivered via email. Report can be used by individual purchaser only.
Single User Licence
$3500
Electronic PDF copy delivered via email. Report can be shared by unlimited users within one corporate location, e.g. a regional office.
Site Licence
$7000
Electronic PDF copy delivered via email. Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company.
Global Licence
$10500
Email to a colleague Enquire Before Buying
Prefer to speak to a team member? Call us on:
+44 161 359 5414
Or click here to contact us
Secure Payments
Cards